PubMed:8496188
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-52 | Sentence | denotes | Oxidoreductive regulation of nuclear factor kappa B. |
| T2 | 53-109 | Sentence | denotes | Involvement of a cellular reducing catalyst thioredoxin. |
| T3 | 110-401 | Sentence | denotes | We have investigated an oxidoreductive regulatory pathway for the DNA binding activity of a pleiotropic cellular transcription factor, nuclear factor kappa B (NF kappa B), has been investigated by using NF kappa B prepared from the nucleus and the cytosol of the primary human T lymphocytes. |
| T4 | 402-616 | Sentence | denotes | We show that a cellular reducing catalyst thioredoxin (Trx) plays a major role in activation of the DNA binding of NF kappa B in vitro and stimulation of transcription from the NF kappa B-dependent gene expression. |
| T5 | 617-824 | Sentence | denotes | We demonstrate evidence suggesting that redox regulation of NF kappa B by Trx might be exerted at a step after dissociation of the inhibitory molecule I kappa B, a cytosolic-anchoring protein for NF kappa B. |
| T6 | 825-1082 | Sentence | denotes | To examine the effect of Trx in intact cells, we performed transient assay with a chloramphenicol acetyltransferase-expressing plasmid under the control of human immunodeficiency virus (HIV) long terminal repeat and an effector plasmid expressing human Trx. |
| T7 | 1083-1263 | Sentence | denotes | The promoter activity from HIV long terminal repeat was greatly augmented by co-transfecting the Trx-expressing plasmid, whose effect was dependent on the NF kappa B-binding sites. |
| T8 | 1264-1513 | Sentence | denotes | These findings have suggested that cysteine residue(s) of NF kappa B might be involved in the DNA-recognition by NF kappa B and that the redox control mechanism mediated by Trx might have a regulatory role in the NF kappa B-mediated gene expression. |
| T9 | 1514-1657 | Sentence | denotes | These results may also provide a clue to understanding of the molecular process of AIDS pathogenesis and its possible biochemical intervention. |
| T1 | 0-52 | Sentence | denotes | Oxidoreductive regulation of nuclear factor kappa B. |
| T2 | 53-109 | Sentence | denotes | Involvement of a cellular reducing catalyst thioredoxin. |
| T3 | 110-401 | Sentence | denotes | We have investigated an oxidoreductive regulatory pathway for the DNA binding activity of a pleiotropic cellular transcription factor, nuclear factor kappa B (NF kappa B), has been investigated by using NF kappa B prepared from the nucleus and the cytosol of the primary human T lymphocytes. |
| T4 | 402-616 | Sentence | denotes | We show that a cellular reducing catalyst thioredoxin (Trx) plays a major role in activation of the DNA binding of NF kappa B in vitro and stimulation of transcription from the NF kappa B-dependent gene expression. |
| T5 | 617-824 | Sentence | denotes | We demonstrate evidence suggesting that redox regulation of NF kappa B by Trx might be exerted at a step after dissociation of the inhibitory molecule I kappa B, a cytosolic-anchoring protein for NF kappa B. |
| T6 | 825-1082 | Sentence | denotes | To examine the effect of Trx in intact cells, we performed transient assay with a chloramphenicol acetyltransferase-expressing plasmid under the control of human immunodeficiency virus (HIV) long terminal repeat and an effector plasmid expressing human Trx. |
| T7 | 1083-1263 | Sentence | denotes | The promoter activity from HIV long terminal repeat was greatly augmented by co-transfecting the Trx-expressing plasmid, whose effect was dependent on the NF kappa B-binding sites. |
| T8 | 1264-1513 | Sentence | denotes | These findings have suggested that cysteine residue(s) of NF kappa B might be involved in the DNA-recognition by NF kappa B and that the redox control mechanism mediated by Trx might have a regulatory role in the NF kappa B-mediated gene expression. |
| T9 | 1514-1657 | Sentence | denotes | These results may also provide a clue to understanding of the molecular process of AIDS pathogenesis and its possible biochemical intervention. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 29-51 | protein | denotes | nuclear factor kappa B |
| T2 | 97-108 | protein | denotes | thioredoxin |
| T3 | 202-243 | protein | denotes | pleiotropic cellular transcription factor |
| T4 | 245-267 | protein | denotes | nuclear factor kappa B |
| T5 | 269-279 | protein | denotes | NF kappa B |
| T6 | 313-323 | protein | denotes | NF kappa B |
| T7 | 373-400 | cell_type | denotes | primary human T lymphocytes |
| T8 | 444-455 | protein | denotes | thioredoxin |
| T9 | 457-460 | protein | denotes | Trx |
| T10 | 517-527 | protein | denotes | NF kappa B |
| T11 | 579-589 | protein | denotes | NF kappa B |
| T12 | 677-687 | protein | denotes | NF kappa B |
| T13 | 691-694 | protein | denotes | Trx |
| T14 | 768-777 | protein | denotes | I kappa B |
| T15 | 781-808 | protein | denotes | cytosolic-anchoring protein |
| T16 | 813-823 | protein | denotes | NF kappa B |
| T17 | 850-853 | protein | denotes | Trx |
| T18 | 907-959 | DNA | denotes | chloramphenicol acetyltransferase-expressing plasmid |
| T19 | 981-1036 | DNA | denotes | human immunodeficiency virus (HIV) long terminal repeat |
| T20 | 1044-1060 | DNA | denotes | effector plasmid |
| T21 | 1072-1081 | protein | denotes | human Trx |
| T22 | 1110-1134 | DNA | denotes | HIV long terminal repeat |
| T23 | 1180-1202 | DNA | denotes | Trx-expressing plasmid |
| T24 | 1238-1248 | protein | denotes | NF kappa B |
| T25 | 1322-1332 | protein | denotes | NF kappa B |
| T26 | 1377-1387 | protein | denotes | NF kappa B |
| T27 | 1437-1440 | protein | denotes | Trx |
| T28 | 1477-1487 | protein | denotes | NF kappa B |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-52 | Sentence | denotes | Oxidoreductive regulation of nuclear factor kappa B. |
| S2 | 53-109 | Sentence | denotes | Involvement of a cellular reducing catalyst thioredoxin. |
| S3 | 110-401 | Sentence | denotes | We have investigated an oxidoreductive regulatory pathway for the DNA binding activity of a pleiotropic cellular transcription factor, nuclear factor kappa B (NF kappa B), has been investigated by using NF kappa B prepared from the nucleus and the cytosol of the primary human T lymphocytes. |
| S4 | 402-616 | Sentence | denotes | We show that a cellular reducing catalyst thioredoxin (Trx) plays a major role in activation of the DNA binding of NF kappa B in vitro and stimulation of transcription from the NF kappa B-dependent gene expression. |
| S5 | 617-824 | Sentence | denotes | We demonstrate evidence suggesting that redox regulation of NF kappa B by Trx might be exerted at a step after dissociation of the inhibitory molecule I kappa B, a cytosolic-anchoring protein for NF kappa B. |
| S6 | 825-1082 | Sentence | denotes | To examine the effect of Trx in intact cells, we performed transient assay with a chloramphenicol acetyltransferase-expressing plasmid under the control of human immunodeficiency virus (HIV) long terminal repeat and an effector plasmid expressing human Trx. |
| S7 | 1083-1263 | Sentence | denotes | The promoter activity from HIV long terminal repeat was greatly augmented by co-transfecting the Trx-expressing plasmid, whose effect was dependent on the NF kappa B-binding sites. |
| S8 | 1264-1513 | Sentence | denotes | These findings have suggested that cysteine residue(s) of NF kappa B might be involved in the DNA-recognition by NF kappa B and that the redox control mechanism mediated by Trx might have a regulatory role in the NF kappa B-mediated gene expression. |
| S9 | 1514-1657 | Sentence | denotes | These results may also provide a clue to understanding of the molecular process of AIDS pathogenesis and its possible biochemical intervention. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 29-51 | NP | denotes | nuclear factor kappa B |
| C2 | 200-243 | NP | denotes | a pleiotropic cellular transcription factor |
| C3 | 245-280 | NP | denotes | nuclear factor kappa B (NF kappa B) |
| C4 | 313-323 | NP | denotes | NF kappa B |
| C5 | 444-461 | NP | denotes | thioredoxin (Trx) |
| C6 | 517-527 | NP | denotes | NF kappa B |
| C7 | 575-615 | NP | denotes | the NF kappa B-dependent gene expression |
| C8 | 677-687 | NP | denotes | NF kappa B |
| C9 | 691-694 | NP | denotes | Trx |
| C10 | 744-777 | NP | denotes | the inhibitory molecule I kappa B |
| C12 | 813-823 | NP | denotes | NF kappa B |
| C11 | 779-823 | NP | denotes | a cytosolic-anchoring protein for NF kappa B |
| C13 | 850-853 | NP | denotes | Trx |
| C14 | 981-1036 | NP | denotes | human immunodeficiency virus (HIV) long terminal repeat |
| C16 | 1072-1081 | NP | denotes | human Trx |
| C15 | 1041-1081 | NP | denotes | an effector plasmid expressing human Trx |
| C17 | 1110-1134 | NP | denotes | HIV long terminal repeat |
| C19 | 1180-1184 | NP | denotes | Trx- |
| C18 | 1176-1202 | NP | denotes | the Trx-expressing plasmid |
| C20 | 1204-1209 | NP | denotes | whose |
| C21 | 1238-1249 | NP | denotes | NF kappa B- |
| C22 | 1322-1332 | NP | denotes | NF kappa B |
| C23 | 1377-1387 | NP | denotes | NF kappa B |
| C24 | 1437-1440 | NP | denotes | Trx |
| C25 | 1473-1512 | NP | denotes | the NF kappa B-mediated gene expression |
| C26 | 1572-1614 | NP | denotes | the molecular process of AIDS pathogenesis |
| C27 | 1619-1622 | NP | denotes | its |
| R1 | C1 | C3 | coref-ident | nuclear factor kappa B,nuclear factor kappa B (NF kappa B) |
| R2 | C3 | C2 | coref-appos | nuclear factor kappa B (NF kappa B),a pleiotropic cellular transcription factor |
| R3 | C4 | C3 | coref-ident | NF kappa B,nuclear factor kappa B (NF kappa B) |
| R4 | C6 | C4 | coref-ident | NF kappa B,NF kappa B |
| R5 | C8 | C6 | coref-ident | NF kappa B,NF kappa B |
| R6 | C9 | C5 | coref-ident | Trx,thioredoxin (Trx) |
| R7 | C12 | C6 | coref-ident | NF kappa B,NF kappa B |
| R8 | C11 | C10 | coref-appos | a cytosolic-anchoring protein for NF kappa B,the inhibitory molecule I kappa B |
| R9 | C13 | C9 | coref-ident | Trx,Trx |
| R10 | C16 | C13 | coref-ident | human Trx,Trx |
| R11 | C17 | C14 | coref-ident | HIV long terminal repeat,human immunodeficiency virus (HIV) long terminal repeat |
| R12 | C19 | C16 | coref-ident | Trx-,human Trx |
| R13 | C18 | C15 | coref-ident | the Trx-expressing plasmid,an effector plasmid expressing human Trx |
| R14 | C20 | C18 | coref-relat | whose,the Trx-expressing plasmid |
| R15 | C21 | C12 | coref-ident | NF kappa B-,NF kappa B |
| R16 | C22 | C21 | coref-ident | NF kappa B,NF kappa B- |
| R17 | C23 | C22 | coref-ident | NF kappa B,NF kappa B |
| R18 | C24 | C16 | coref-ident | Trx,human Trx |
| R19 | C25 | C7 | coref-other | the NF kappa B-mediated gene expression,the NF kappa B-dependent gene expression |
| R20 | C27 | C26 | coref-pron | its,the molecular process of AIDS pathogenesis |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-25 | other_name | denotes | Oxidoreductive regulation |
| T2 | 29-51 | protein_molecule | denotes | nuclear factor kappa B |
| T3 | 97-108 | protein_molecule | denotes | thioredoxin |
| T4 | 134-167 | other_name | denotes | oxidoreductive regulatory pathway |
| T5 | 176-196 | other_name | denotes | DNA binding activity |
| T6 | 202-243 | protein_family_or_group | denotes | pleiotropic cellular transcription factor |
| T7 | 245-267 | protein_molecule | denotes | nuclear factor kappa B |
| T8 | 269-279 | protein_molecule | denotes | NF kappa B |
| T9 | 313-323 | protein_molecule | denotes | NF kappa B |
| T10 | 342-349 | cell_component | denotes | nucleus |
| T11 | 358-365 | cell_component | denotes | cytosol |
| T12 | 373-400 | cell_type | denotes | primary human T lymphocytes |
| T13 | 444-455 | protein_molecule | denotes | thioredoxin |
| T14 | 457-460 | protein_molecule | denotes | Trx |
| T15 | 517-527 | protein_molecule | denotes | NF kappa B |
| T16 | 579-589 | protein_molecule | denotes | NF kappa B |
| T17 | 677-687 | protein_molecule | denotes | NF kappa B |
| T18 | 691-694 | protein_molecule | denotes | Trx |
| T19 | 768-777 | protein_molecule | denotes | I kappa B |
| T20 | 781-808 | protein_family_or_group | denotes | cytosolic-anchoring protein |
| T21 | 813-823 | protein_molecule | denotes | NF kappa B |
| T22 | 850-853 | protein_molecule | denotes | Trx |
| T23 | 884-899 | other_name | denotes | transient assay |
| T24 | 907-922 | other_organic_compound | denotes | chloramphenicol |
| T25 | 981-1036 | DNA_domain_or_region | denotes | human immunodeficiency virus (HIV) long terminal repeat |
| T26 | 1044-1060 | DNA_molecule | denotes | effector plasmid |
| T27 | 1072-1081 | protein_molecule | denotes | human Trx |
| T28 | 1087-1104 | other_name | denotes | promoter activity |
| T29 | 1110-1134 | DNA_domain_or_region | denotes | HIV long terminal repeat |
| T30 | 1180-1202 | DNA_molecule | denotes | Trx-expressing plasmid |
| T31 | 1238-1248 | protein_molecule | denotes | NF kappa B |
| T32 | 1299-1315 | amino_acid_monomer | denotes | cysteine residue |
| T33 | 1322-1332 | protein_molecule | denotes | NF kappa B |
| T34 | 1377-1387 | protein_molecule | denotes | NF kappa B |
| T35 | 1437-1440 | protein_molecule | denotes | Trx |
| T36 | 1477-1487 | protein_family_or_group | denotes | NF kappa B |
| T37 | 1597-1601 | other_name | denotes | AIDS |
| T38 | 1632-1656 | other_name | denotes | biochemical intervention |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 987-1003 | Phenotype | denotes | immunodeficiency | HP:0002721 |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 987-1003 | Disease | denotes | immunodeficiency | http://purl.obolibrary.org/obo/MONDO_0021094 |
| T2 | 1597-1601 | Disease | denotes | AIDS | http://purl.obolibrary.org/obo/MONDO_0012268 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 381-386 | OrganismTaxon | denotes | human | 9606 |
| T2 | 981-986 | OrganismTaxon | denotes | human | 9606 |
| T3 | 1072-1077 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 342-349 | Body_part | denotes | nucleus | http://purl.obolibrary.org/obo/GO_0005634|http://purl.obolibrary.org/obo/UBERON_0000125 |
| T3 | 358-365 | Body_part | denotes | cytosol | http://purl.obolibrary.org/obo/GO_0005829 |
| T4 | 387-400 | Body_part | denotes | T lymphocytes | http://purl.obolibrary.org/obo/CL_0000084 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 387-400 | Cell | denotes | T lymphocytes | http://purl.obolibrary.org/obo/CL:0000084 |